insights_auto
Hvorfor har EVGN gått ned? 4,99%?
Gå mer i dybdenchevron_right
EVGN:NASDAQ
Evogene Ltd
0,40 USD
arrow_downward
−4,99%(−0,021) 1 D
0,38 USD
arrow_downward
−6,64% (−0,027)bedtimeEtter stengetid
Stengt: 5. okt., 16:00:01 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EVGN …
Åpne
0,41 USD
Høy
0,41 USD
Lav
0,37 USD
Markedsverdi
6,31 mill.
Snittvolum
2,57 mill.
Volum
595,95k
52 u høy
1,50 USD
52 u lav
0,35 USD
EPS
−0,91 USD
Beta
1,44
Utestående aksjer
15,80 mill.
Antall ansatte
52
Åpne
0,41 USD
Høy
0,41 USD
Lav
0,37 USD
Markedsverdi
6,31 mill.
Snittvolum
2,57 mill.
Volum
595,95k
52 u høy
1,50 USD
52 u lav
0,35 USD
EPS
−0,91 USD
Beta
1,44
Utestående aksjer
15,80 mill.
Antall ansatte
52
Nyhetssaker
Fra nettkilder og nyhetspartnere
AD HOC NEWS
·
for 15 timer siden
Evogene stock fell 2.43 percent as Nasdaq deadline moved
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Om Evogene Ltd